medicina58巻5号

2021年04月発行

特集 その考えはもう古い！—最新・感染症診療 診断・治療の最新の考え方 〈治療薬・治療法再考〉

メチシリン耐性黄色ブドウ球菌（MRSA）—どんなときにカバーし，どう治療する？

著者： 冲中敬二¹²

所属機関： ¹国立がん研究センター東病院総合内科 ²国立がん研究センター中央病院造血幹細胞移植科

ページ範囲：P.635 - P.640

Point
◎黄色ブドウ球菌は病原性が強く，播種性感染症のリスクが高い．
◎広域抗菌薬を経験的に開始する際は，終了するための条件を念頭に置く．
◎経験的に開始した場合は，臨床経過や培養検査結果などをもとに，抗MRSA薬の継続の必要性について日々検討する．
◎第一選択はバンコマイシン（VCM）であるが，副作用などの問題がある場合は他剤への変更も考慮する．

参考文献

；Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10：505-520, 1997

among 104 healthy persons during a 19-month period. Epidemiol Infect 115：51-60, 1995

in home care settings；Prevalence, duration, and transmission to household members. Arch Intern Med 169：1372-1378, 2009

. Nat Rev Dis Primers 4：18034, 2018

leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis 191：1771-1777, 2005

interactions with the endothelium；The role of bacterial “secretable expanded repertoire adhesive molecules”（SERAM）in disturbing host defense systems. Thromb Haemost 94：278-285, 2005

clones increased in Japanese hospitals. J Med Microbiol 67：769-774, 2018

USA300 clone in multiple hospitals in Tokyo, Japan. Clin Microbiol Infect 24：1211 e1-e7, 2018

infection after recent cischarge from an acute-care hospitalization, 2011-2013. Clin Infect Dis 62：45-52, 2016

（MRSA）nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39：776-782, 2004

11）Svetitsky S, et al：Comparative efficacy and safety of vancomycin versus teicoplanin；Systematic review and meta-analysis. Antimicrob Agents Chemother 53：4069-4079, 2009

12）Cavalcanti AB, et al：Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev 6：CD007022, 2010

（MRSA）in a patient with recurrent bacteraemia. J Antimicrob Chemother 57：699-704, 2006

. Clin Infect Dis 38：448-451, 2004

with reduced vancomycin susceptibility. Clin Infect Dis 38：521-528, 2004

16）Lodise TP, et al：Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 49：507-514, 2009

infections；A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77：835-864, 2020

infections；A systematic review and meta-analysis. Clin Infect Dis 54：755-771, 2012

19）MRSA感染症の治療ガイドライン作成委員会（編）：MRSA感染症の治療ガイドライン改訂版2019．　http://www.chemotherapy.or.jp/guideline/guideline_mrsa_2019.pdf（2020年12月閲覧）

infections-a systematic review and meta-analysis. Clin Microbiol Infect 24：97-104, 2018

. Clin Infect Dis 42：1652-1653, 2006

（MRSA）blood isolates from 2001-05. J Antimicrob Chemother 60：788-794, 2007

23）Figueroa DA, et al：Safety of high-dose intravenous daptomycin treatment；Three-year cumulative experience in a clinical program. Clin Infect Dis 49：177-180, 2009

bacteremia. Clin Infect Dis 57：1568-1576, 2013

25）Yue J, et al：Linezolid versus vancomycin for skin and soft tissue infections. Cochrane Database Syst Rev 1：CD008056, 2016

26）McCool R, et al：Systematic review and network meta-analysis of tedizolid for the treatment of acute bacterial skin and skin structure infections caused by MRSA. BMC Infect Dis 17：39, 2017

bacteremia；A meta-analysis. Clin Infect Dis 36：53-59, 2003

28）Baddour LM, et al：Infective endocarditis in adults；Diagnosis, antimicrobial therapy, and management of complications；A scientific statement for healthcare professionals from the American Heart Association. Circulation 132：1435-1486, 2015

bacteremia；A pilot multicenter randomized controlled trial. Clin Infect Dis 62：173-180, 2016

bacteremia. Antimicrob Agents Chemother 63：e02483-18, 2019

31）Tong SYC, et al：Effect of vancomycin or daptomycin with vs without an antistaphylococcal beta-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia；A randomized clinical trial. JAMA 323：527-537, 2020

32）Talan DA, et al：Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skins abscess. N Engl J Med 374：823-832, 2016

33）Daum RS, et al：A placebo-controlled trial of antibiotics for smaller skin abscesses. N Engl J Med 376：2545-2555, 2017

infections in Taiwan. J Microbiol Immunol Infect 46：147-150, 2013

bacteremia；A systematic review and meta-analysis. J Infect 72：19-28, 2016

bacteremia. Clin Infect Dis 56：527-535, 2013